Announcing a new article publication for BIO Integration journal. In this article the authors Chunxiong Zheng, Mingqiang Li and Jianxun Ding from Sun Yat-sen University, Guangzhou, China and Changchun ...
NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services
PRINCETON, N.J., November 06, 2025--(BUSINESS WIRE)--NJ Bio, Inc., a premier contract research and clinical manufacturing service provider in Princeton, New Jersey has announced the asset purchase and ...
Sanofi, which previously reported slower timelines than most other drugmakers working on COVID-19 vaccines, now purports it may receive approval for two vaccines in 2021, according to STAT. Phase 1/2 ...
Cliniphai, an AI Agent and Framework platform purpose-built to solve complex challenges in life sciences, today announced the next phase of its flagship platform, Athena, at the BIO International ...
CAMBRIDGE, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced data today from ...
NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services
NJ Bio, Inc., a premier contract research and clinical manufacturing service provider in Princeton, New Jersey has announced the asset purchase and full integration of the research services of L2P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback